{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:35:05Z","timestamp":1762504505331},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,27]]},"DOI":"10.7759\/cureus.22669","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T06:52:32Z","timestamp":1646031152000},"source":"Crossref","is-referenced-by-count":5,"title":["Lichen Planus Eruption Following Oxford-AstraZeneca COVID-19 Vaccine Administration: A Case Report and Review of Literature"],"prefix":"10.7759","author":[{"given":"Hamzah M","family":"Alrawashdah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Al-Habahbeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah Y","family":"Naser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hashem","family":"Abu Serhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanar","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Aldalameh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Coronavirus disease (COVID-19) outbreak. (2021). Accessed: September 22, 2021: https:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/news\/news\/2020\/3\/who-announces-covi...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/v12050526","article-title":"SARS-CoV-2\/COVID-19: viral genomics, epidemiology, vaccines, and therapeutic interventions","volume":"12","author":"Uddin M","year":"2020","unstructured":"Uddin M, Mustafa F, Rizvi TA, et al.. SARS-CoV-2\/COVID-19: viral genomics, epidemiology, vaccines, and therapeutic interventions. Viruses. 2020, 12:10.3390\/v12050526","journal-title":"Viruses"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.28.2100563","article-title":"Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021","volume":"26","author":"Harder T","year":"2021","unstructured":"Harder T, Koch J, Vygen-Bonnet S, et al.. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021. Euro Surveill. 2021, 26:10.2807\/1560-7917.ES.2021.26.28.2100563","journal-title":"Euro Surveill"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00628-0","article-title":"Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012\/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial","volume":"397","author":"Emary KR","year":"2021","unstructured":"Emary KR, Golubchik T, Aley PK, et al.. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012\/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021, 397:1351-62. 10.1016\/S0140-6736(21)00628-0","journal-title":"Lancet"},{"key":"ref5","unstructured":"WHO Timeline\u2014COVID-19. (2020). Accessed. June 20, 2020: https:\/\/www.who.int\/news-room\/detail\/ 27-04-2020-WHO-timeline-covid-19."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17343","article-title":"Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy","volume":"35","author":"Farinazzo E","year":"2021","unstructured":"Farinazzo E, Ponis G, Zelin E, et al.. Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy. J Eur Acad Dermatol Venereol. 2021, 35:e548-51. 10.1111\/jdv.17343","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17221","article-title":"Lichen planus arising after COVID-19 vaccination","volume":"35","author":"Hiltun I","year":"2021","unstructured":"Hiltun I, Sarriugarte J, Mart\u00ednez-de-Espronceda I, Garc\u00e9s A, Llanos C, Vives R, Yanguas JI. Lichen planus arising after COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021, 35:e414-5. 10.1111\/jdv.17221","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2021.05.016","article-title":"COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide","volume":"39","author":"Sun Q","year":"2021","unstructured":"Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide. Dermatol Clin. 2021, 39:653-73. 10.1016\/j.det.2021.05.016","journal-title":"Dermatol Clin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15129","article-title":"Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: case report and brief literature review","volume":"34","author":"Pedrazini MC","year":"2021","unstructured":"Pedrazini MC, da Silva MH. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: case report and brief literature review. Dermatol Ther. 2021, 34:e15129. 10.1111\/dth.15129","journal-title":"Dermatol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.752443","article-title":"Case report: pityriasis rosea-like eruption following COVID-19 vaccination","volume":"8","author":"Leerunyakul K","year":"2021","unstructured":"Leerunyakul K, Pakornphadungsit K, Suchonwanit P. Case report: pityriasis rosea-like eruption following COVID-19 vaccination. Front Med (Lausanne). 2021, 8:752443. 10.3389\/fmed.2021.752443","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2021.10.002","article-title":"Erythema nodosum, after Medigen vaccination against COVID-19?","author":"Hsu HT","year":"2021","unstructured":"Hsu HT, Su HA, Chen YC. Erythema nodosum, after Medigen vaccination against COVID-19?. J Formos Med Assoc. 2021, 10.1016\/j.jfma.2021.10.002","journal-title":"J Formos Med Assoc"},{"key":"ref12","article-title":"[Lichen planus, a T-lymphocyte mediated reaction involving the skin and mucous membranes]","volume":"145","author":"van den Akker TW","year":"2001","unstructured":"van den Akker TW. [Lichen planus, a T-lymphocyte mediated reaction involving the skin and mucous membranes]. Ned Tijdschr Geneeskd. 2001, 145:1921-8.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.010","article-title":"Lichen planus and lichenoid dermatoses: clinical overview and molecular basis","volume":"79","author":"Tziotzios C","year":"2018","unstructured":"Tziotzios C, Lee JY, Brier T, et al.. Lichen planus and lichenoid dermatoses: clinical overview and molecular basis. J Am Acad Dermatol. 2018, 79:789-804. 10.1016\/j.jaad.2018.02.010","journal-title":"J Am Acad Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.5522","article-title":"Lichen planus","volume":"151","author":"Berger TG","year":"2015","unstructured":"Berger TG. Lichen planus. JAMA Dermatol. 2015, 151:356. 10.1001\/jamadermatol.2014.5522","journal-title":"JAMA Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon DE","year":"2021","unstructured":"McMahon DE, Amerson E, Rosenbach M, et al.. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021, 85:46-55. 10.1016\/j.jaad.2021.03.092","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.032","article-title":"Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists","volume":"61","author":"Asarch A","year":"2009","unstructured":"Asarch A, Gottlieb AB, Lee J, et al.. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol. 2009, 61:104-11. 10.1016\/j.jaad.2008.09.032","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1103641","article-title":"Clinical practice. Lichen planus","volume":"366","author":"Le Cleach L","year":"2012","unstructured":"Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med. 2012, 366:723-32. 10.1056\/NEJMcp1103641","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16525","article-title":"Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic","volume":"34","author":"Kasperkiewicz M","year":"2020","unstructured":"Kasperkiewicz M, Schmidt E, Fairley JA, et al.. Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2020, 34:e302-3. 10.1111\/jdv.16525","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06257.x","article-title":"Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review","volume":"151","author":"Lodi G","year":"2004","unstructured":"Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Demarosi F, Carrassi A. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol. 2004, 151:1172-81. 10.1111\/j.1365-2133.2004.06257.x","journal-title":"Br J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03396.x","article-title":"Direct immunofluorescence study in patients with lichen planus","volume":"46","author":"Kulthanan K","year":"2007","unstructured":"Kulthanan K, Jiamton S, Varothai S, Pinkaew S, Sutthipinittharm P. Direct immunofluorescence study in patients with lichen planus. Int J Dermatol. 2007, 46:1237-41. 10.1111\/j.1365-4632.2007.03396.x","journal-title":"Int J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.04062.x","article-title":"Lichen planus","volume":"48","author":"Lehman JS","year":"2009","unstructured":"Lehman JS, Tollefson MM, Gibson LE. Lichen planus. Int J Dermatol. 2009, 48:682-94. 10.1111\/j.1365-4632.2009.04062.x","journal-title":"Int J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05113.x","article-title":"Lichen planus and lichenoid drug-induced eruption: a histological and immunohistochemical study","volume":"51","author":"Lage D","year":"2012","unstructured":"Lage D, Juliano PB, Metze K, de Souza EM, Cintra ML. Lichen planus and lichenoid drug-induced eruption: a histological and immunohistochemical study. Int J Dermatol. 2012, 51:1199-205. 10.1111\/j.1365-4632.2011.05113.x","journal-title":"Int J Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12275","article-title":"The significance of eosinophils in hypertrophic lichen planus","volume":"41","author":"Alomari A","year":"2014","unstructured":"Alomari A, McNiff JM. The significance of eosinophils in hypertrophic lichen planus. J Cutan Pathol. 2014, 41:347-52. 10.1111\/cup.12275","journal-title":"J Cutan Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5092","article-title":"Lichen planus flare following COVID-19 vaccination: a case report","volume":"9","author":"Herzum A","year":"2021","unstructured":"Herzum A, Burlando M, Molle MF, Micalizzi C, Cozzani E, Parodi A. Lichen planus flare following COVID-19 vaccination: a case report. Clin Case Rep. 2021, 9:e05092. 10.1002\/ccr3.5092","journal-title":"Clin Case Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17504","article-title":"New-onset cutaneous lichen planus triggered by COVID-19 vaccination","volume":"35","author":"Merhy R","year":"2021","unstructured":"Merhy R, Sarkis AS, Kaikati J, El Khoury L, Ghosn S, Stephan F. New-onset cutaneous lichen planus triggered by COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021, 35:e729-30. 10.1111\/jdv.17504","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S315727","article-title":"Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety","volume":"14","author":"Mascellino MT","year":"2021","unstructured":"Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist. 2021, 14:3459-76. 10.2147\/IDR.S315727","journal-title":"Infect Drug Resist"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640093","article-title":"Two different antibody-dependent enhancement (ADE) risks for SARS-CoV-2 antibodies","volume":"12","author":"Ricke DO","year":"2021","unstructured":"Ricke DO. Two different antibody-dependent enhancement (ADE) risks for SARS-CoV-2 antibodies. Front Immunol. 2021, 12:640093. 10.3389\/fimmu.2021.640093","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00789-5","article-title":"Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies","volume":"5","author":"Lee WS","year":"2020","unstructured":"Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020, 5:1185-91. 10.1038\/s41564-020-00789-5","journal-title":"Nat Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/85859-lichen-planus-eruption-following-oxford-astrazeneca-covid-19-vaccine-administration-a-case-report-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:23Z","timestamp":1707507563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/85859-lichen-planus-eruption-following-oxford-astrazeneca-covid-19-vaccine-administration-a-case-report-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,27]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.22669","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,27]]}}}